Comparative evaluation shows rapid test’s accuracy in detecting hepatitis B, indicating cost-effective diagnostics.
ICT showed excellent diagnostic accuracy comparable to ELISA, supporting its use as a reliable and cost-effective screening tool in clinical and resource-limited settings. However, borderline results require confirmatory testing with ELISA or molecular methods. This study aligns with the United Nations Sustainable Development Goal 3: Good Health and Well-Being by supporting the development of affordable and accessible diagnostics for the elimination of viral hepatitis.
No takes yet. Share an insight, caveat, or question.
Raja et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: